Lunai Bioworks Inc.: 10-Q filed 2021-11-15

Name: Lunai Bioworks Inc.: 10-Q filed 2021-11-15
Creator: Lunai Bioworks Inc.

What Lunai Bioworks Inc. reported in its quarterly report filed 2021-11-15 (fiscal Q1 2022): 38 published measures, 79 facts as tagged in accession 0001731122-21-001934.

This filing

Form: 10-Q (quarterly report)
Filed: 2021-11-15
Fiscal period: fiscal Q1 2022
Accession: 0001731122-21-001934 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Lunai Bioworks Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2021-09-30	184,064,717	USD
At 2021-06-30	189,605,225	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2021-09-30	166,974,952	USD
At 2021-06-30	174,662,939	USD
At 2020-09-30	164,230,236	USD
At 2020-06-30	166,272,261	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2021-09-30	15,377,050	USD
At 2021-06-30	20,664,410	USD
At 2020-09-30	5,695,661	USD
At 2020-06-30	8,696,361	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-10,411,969	USD	92
2020-07-01 to 2020-09-30	-2,396,570	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-5,276,687	USD	92
2020-07-01 to 2020-09-30	-2,755,665	USD	92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	5,156	USD	92
2020-07-01 to 2020-09-30	0	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	0	USD	92
2020-07-01 to 2020-09-30	0	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-5,156	USD	92
2020-07-01 to 2020-09-30	0	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2021-09-30	-101,323,774	USD
At 2021-06-30	-90,911,805	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	34	USD	92
2020-07-01 to 2020-09-30	-122,794	USD	92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2021-09-30	696,713	USD
At 2021-06-30	719,364	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	2,727,975	USD	92
2020-07-01 to 2020-09-30	326,156	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-7,504,673	USD	92
2020-07-01 to 2020-09-30	-2,858,757	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2021-09-30	15,455,162	USD
At 2021-06-30	20,898,993	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	89,739	USD	92
2020-07-01 to 2020-09-30	92,313	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2021-09-30	1,210,531	USD
At 2021-06-30	1,885,893	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2021-09-30	11,640,000	USD
At 2021-06-30	11,640,000	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2021-09-30	60,537	USD
At 2021-06-30	65,906	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	3,006,243	USD	92
2020-07-01 to 2020-09-30	1,050,376	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2021-09-30	52,219,661	shares
At 2021-06-30	52,219,661	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2021-09-30	268,308,331	USD
At 2021-06-30	265,580,356	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2021-09-30	-14,827	USD
At 2021-06-30	-10,834	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2021-09-30	1,367,321	USD
At 2021-06-30	1,435,978	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2021-09-30	985,180	USD
At 2021-06-30	980,025	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2021-09-30	288,467	USD
At 2021-06-30	260,661	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2021-09-30	167,912,842	USD
At 2021-06-30	167,986,868	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2021-09-30	364,769	USD
At 2021-06-30	1,182,323	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-10,411,969	USD	92
2020-07-01 to 2020-09-30	-2,396,570	USD	92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-10,415,962	USD	92
2020-07-01 to 2020-09-30	-2,368,181	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	4,466,697	USD	92
2020-07-01 to 2020-09-30	1,777,923	USD	92

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	27,806	USD	92
2020-07-01 to 2020-09-30	26,545	USD	92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	31,733	USD	92
2020-07-01 to 2020-09-30	30,458	USD	92

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	3,927	USD	92
2020-07-01 to 2020-09-30	3,913	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-2,907,262	USD	92
2020-07-01 to 2020-09-30	339,393	USD	92

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	36,462	USD	92
2020-07-01 to 2020-09-30	42,365	USD	92

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	34	USD	92
2020-07-01 to 2020-09-30	37	USD	92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	74,054	USD	92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	227,306	USD	92
2020-07-01 to 2020-09-30	-310,501	USD	92

Inspect the source

Entity: Lunai Bioworks Inc. / CIK 0001527728
Captured: 2026-09-19 11:18 UTC
SEC response SHA-256: ac98dc0ce9d3f6a81ccca9ca1f946e5772f94eabe3529dac2d726fef17abed57

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001527728.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))